Factors | Univariate | Multivariate | |||
---|---|---|---|---|---|
DGE | |||||
Yes (n = 21) | No (n = 84) | P-value | Odds ratio (95% CI) | P-value | |
Sex (male, %) | 13 (61.9) | 51 (60.7) | 0.9203 | ||
Age (years), mean ± standard deviation | 71 ± 8 | 70 ± 10 | 0.7734 | ||
BMI (kg/m2), mean ± standard deviation | 22.1 ± 2.9 | 20.9 ± 3.6 | 0.1746 | ||
Diabetes mellitus (yes, %) | 5 (23.8) | 33 (39.3) | 0.1759 | ||
Current smoker (yes, %) | 2 (9.5) | 14 (16.7) | 0.3933 | ||
Preoperative obstructive jaundice (Yes, %) | 14 (66.7) | 34 (40.5) | 0.0306 | 3.13 (0.91–10.82) | 0.0710 |
Tumor size (mm), mean ± standard deviation | 24.8 ± 2.6 | 26.2 ± 1.3 | 0.6037 | ||
Blood vessels invasion (yes, %) | 3 (14.9) | 19 (22.6) | 0.3848 | ||
Malignancy (yes, %) | 18 (85.7) | 69 (82.1) | 0.6925 | ||
Pancreatic gland texture (hard, %) | 7 (33.3) | 37 (44.1) | 0.3689 | ||
Portal vein resection (yes, %) | 3 (14.3) | 16 (19.1) | 0.7895 | ||
Blood loss (g), mean ± standard deviation | 368 ± 243 | 507 ± 407 | 0.1354 | ||
Intraoperative transfusion (yes, %) | 2 (9.5) | 10 (11.9) | 0.6383 | ||
Operative time (min), mean ± standard deviation | 498 ± 109 | 534 ± 104 | 0.1574 | ||
Running pattern of LGV | 0.0011 | ||||
Type 1 | 11 (52.4) | 36 (42.9) | |||
Type 2 | 0 (0.0) | 23 (27.4) | |||
Type 3 | 6 (28.6) | 6 (7.1) | |||
Type 4 | 4 (19.1) | 19 (22.6) | |||
LGV ligation (yes, %) | 12 (57.1) | 7 (8.3) | < 0.0001 | 13.60 (3.80–48.68) | < 0.0001 |
Stapling device for gastroenterostomy (yes, %) | 18 (85.7) | 77 (91.7) | 0.4273 | ||
Roux-en-Y reconstruction (yes, %) | 8 (38.1) | 47 (56.0) | 0.1428 | ||
Grade B or C pancreatic fistula (yes, %) | 12 (57.1) | 23 (27.4) | 0.0116 | 1.70 (0.32–9.17) | 0.5357 |
Wound infection (yes, %) | 4 (19.1) | 6 (7.1) | 0.1242 | ||
Intra-abdominal infection (yes, %) | 8 (38.1) | 16 (19.1) | 0.0749 | ||
Sepsis (yes, %) | 6 (28.6) | 6 (7.1) | 0.0123 | 1.75 (0.31–9.80) | 0.5231 |
Postoperative hospitalisation (days), mean ± standard deviation | 33 ± 12 | 22 ± 14 | 0.0017 |